Recent Stories

New data shows Latinos and Blacks are more likely to contract COVID-19 and die from it, but the data is...

Komen Scholar Ann Partridge, M.D., M.P.H., has dedicated her career to understanding and treating breast cancer in young women.

I tested positive for the BRCA1 mutation, meaning I have an increased risk of developing breast and ovarian cancers.

Thank you, donors, for your generous contributions that make break-through research possible.

Each time I picked up the phone to share that I had cancer with friends and family, they wanted to...

Susan G. Komen's Susan Brown addresses recent news that breast cancer deaths will increase because of COVID-19.

Komen Scholar Joe Gray has a unique and personal perspective on treating breast cancer patients after his wife's metastatic breast...

Patients and doctors should discuss scheduled surgeries in light of COVID-19 developments.

Sherene Loi, FRACP, Ph.D., talked to Susan G. Komen about a clinical trial could immediately change the treatment options for...

I found out I had stage II invasive lobular carcinoma on Mother's Day weekend.

Hear about legislation and regulations that have been enacted in response to COVID-19.

Susan G. Komen's briefing provided an update on MBC and research during COVID-19.